Balance Sheet - BridgeBio Oncology Therapeutics, Inc. (BBOT)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | |
|---|---|---|---|---|---|
| Total cash and short-term investments | 0.43 | 0.13 | 0.00 | 0.00 | 0.00 |
| Accounts receivable, net | 0.00 | ||||
| Other current assets | 0.00 | 0.00 | 0.00 | ||
| Total current assets | 0.43 | 0.00 | 0.00 | ||
| Total non-current assets | 0.02 | 0.19 | 0.00 | 0.00 | 0.00 |
| Total assets | 0.45 | 0.19 | 0.00 | 0.00 | 0.00 |
| Total current liabilities | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total non-current liabilities | 0.00 | 0.01 | 0.10 | ||
| Total liabilities | 0.04 | 0.01 | 0.00 | 0.00 | 0.00 |
| Total stockholders' equity | 0.41 | 0.19 | 0.00 | 0.00 | 0.00 |
| Common shares outstanding | 31 | 17 | 20 | 20 | 20 |
Show Quarterly Balance Sheet
Balance Sheet - BridgeBio Oncology Therapeutics, Inc. (BBOT)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 0.25 | 0.43 | 0.47 | 0.13 | 0.14 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Accounts receivable, net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Other current assets | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Total current assets | 0.27 | 0.43 | 0.48 | 0.14 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Total non-current assets | 0.15 | 0.02 | 0.01 | 0.01 | 0.01 | 0.19 | 0.19 | 0.19 | 0.19 | 0.00 | 0.00 | 0.00 | ||
| Total assets | 0.42 | 0.45 | 0.48 | 0.15 | 0.15 | 0.19 | 0.19 | 0.19 | 0.19 | 0.00 | 0.00 | 0.00 | ||
| Total current liabilities | 0.04 | 0.04 | 0.04 | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Total non-current liabilities | 0.00 | 0.00 | 0.00 | 0.35 | 0.33 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
| Total liabilities | 0.05 | 0.04 | 0.04 | 0.38 | 0.35 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | ||
| Total stockholders' equity | 0.37 | 0.41 | 0.45 | -0.23 | -0.20 | 0.19 | 0.19 | 0.18 | 0.18 | 0.00 | 0.00 | 0.00 | ||
| Common shares outstanding | 31 | 31 | 24 | 24 | 24 | 17 | 24 | 24 | 22 | 20 | 20 | 20 | 20 | 20 |